17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia

Neurobiology of Disease

Volumn 44, Issue 3, 2011, Pages 277-283

  Li, Mingchang ^a,b   Zhang, Zhan ^c   Sun, Weiyun ^a   Koehler, Raymond C ^a   Huang, Judy ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Estrogen; Matrix metalloproteinase; Middle cerebral artery; Thrombolysis

Indexed keywords

ESTRADIOL; GELATINASE A; GELATINASE B; HEMOGLOBIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CONTINUOUS INFUSION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ESTRADIOL; ESTROGENS; FEMALE; FIBRINOLYTIC AGENTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INJECTIONS, SUBCUTANEOUS; INTRACRANIAL HEMORRHAGES; MATRIX METALLOPROTEINASE 9; OVARIECTOMY; RATS; SPECTROPHOTOMETRY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80053289143     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.07.004     Document Type: Article

References (48)

1. Adibhatla R.M., Hatcher J.F. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 2008, 7:243-253.
2. Alexandrov A.V., Hall C.E., Labiche L.A., Wojner A.W., Grotta J.C. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke. Stroke 2004, 35:449-452.
3. Audebert H.J., Kukla C., Vatankhah B., Gotzler B., Schenkel J., Hofer S., Furst A., Haberl R.L. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke 2006, 37:1822-1827.
4. Billeci A.M., Paciaroni M., Caso V., Agnelli G. Hormone replacement therapy and stroke. Curr. Vasc. Pharmacol. 2008, 6:112-123.
5. Chen C.H., Toung T.J., Sapirstein A., Bhardwaj A. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. J. Cereb. Blood Flow Metab. 2006, 26:951-958.
6. Chen T.Y., Lee M.Y., Chen H.Y., Kuo Y.L., Lin S.C., Wu T.S., Lee E.J. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J. Pineal Res. 2006, 40:242-250.
7. Cocho D., Belvis R., Marti-Fabregas J., Molina-Porcel L., Diaz-Manera J., Aleu A., Pagonabarraga J., Garcia-Bargo D., Mauri A., Marti-Vilalta J.L. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005, 64:719-720.
8. Crosby K.M., Connell B.J., Saleh T.M. Estrogen limits ischemic cell death by modulating caspase-12-mediated apoptotic pathways following middle cerebral artery occlusion. Neuroscience 2007, 146:1524-1535.
9. Damczyk M.P., Gardner D.M. Risk of hormone replacement therapy in stroke patients. J. Clin. Pharm. Ther. 2000, 25:239-241.
10. Dubal D.B., Wise P.M. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001, 142:43-48.
11. Fan T., Yang S.H., Johnson E., Osteen B., Hayes R., Day A.L., Simpkins J.W. 17beta-estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Res. 2003, 993:10-17.
12. Fujiwara N., Murata Y., Arai K., Egi Y., Lu J., Wu O., Singhal A.B., Lo E.H. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neurosci. 2009, 10:79.
13. Guo J., Krause D.N., Horne J., Weiss J.H., Li X., Duckles S.P. Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J. Cereb. Blood Flow Metab. 2010, 30:545-554.
14. Jia J., Guan D., Zhu W., Alkayed N.J., Wang M.M., Hua Z., Xu Y. Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp. Neurol. 2009, 215:48-52.
15. Kano T., Harada T., Katayama Y. Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger, edaravone: evaluation in a rat thromboembolic stroke model. Neurol. Res. 2005, 27:499-502.
16. Kelly M.A., Shuaib A., Todd K.G. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp. Neurol. 2006, 200:38-49.
17. Lapchak P.A., Chapman D.F., Zivin J.A. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 2000, 31:3034-3040.
18. Liu R., Wen Y., Perez E., Wang X., Day A.L., Simpkins J.W., Yang S.H. 17beta-estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res. 2005, 1060:55-61.
19. Liu R., Liu Q., He S., Simpkins J.W., Yang S.H. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J. Pharmacol. Exp. Ther. 2010, 332:1006-1012.
20. Lo E.H., Broderick J.P., Moskowitz M.A. tPA and proteolysis in the neurovascular unit. Stroke 2004, 35:354-356.
21. Liu X.S., Zhang Z.G., Zhang L., Morris D.C., Kapke A., Lu M., Chopp M. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab. 2006, 26(6):787-796.
22. Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31:100-106. discussion 106-107.
23. Montaner J., Molina C.A., Monasterio J., Abilleira S., Arenillas J.F., Ribo M., Quintana M., Alvarez-Sabin J. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003, 107:598-603.
24. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002, 288:872-881.
25. O'Donnell M.E., Lam T.I., Tran L.Q., Foroutan S., Anderson S.E. Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 2006, 26:1234-1249.
26. Qin Z., Karabiyikoglu M., Hua Y., Silbergleit R., He Y., Keep R.F., Xi G. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 2007, 38:1362-1367.
27. Rau S.W., Dubal D.B., Bottner M., Gerhold L.M., Wise P.M. Estradiol attenuates programmed cell death after stroke-like injury. J. Neurosci. 2003, 23:11420-11426.
28. Razandi M., Pedram A., Levin E.R. Estrogen signals to the preservation of endothelial cell form and function. J. Biol. Chem. 2000, 275:38540-38546.
29. Razmara A., Krause D.N., Duckles S.P. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1843-H1850.
30. Razmara A., Sunday L., Stirone C., Wang X.B., Krause D.N., Duckles S.P., Procaccio V. Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells. J. Pharmacol. Exp. Ther. 2008, 325:782-790.
31. Rusa R., Alkayed N.J., Crain B.J., Traystman R.J., Kimes A.S., London E.D., Klaus J.A., Hurn P.D. 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999, 30:1665-1670.
32. Saleh T.M., Cribb A.E., Connell B.J. Estrogen-induced recovery of autonomic function after middle cerebral artery occlusion in male rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R1531-R1539.
33. Saleh T.M., Cribb A.E., Connell B.J. Reduction in infarct size by local estrogen does not prevent autonomic dysfunction after stroke. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R2088-R2095.
34. Sumii T., Lo E.H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002, 33:831-836.
35. Tang J., Li Y.J., Mu J., Li Q., Yang D.Y., Xie P. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats. Neurol. Res. 2009, 31:189-194.
36. Toung T.J., Traystman R.J., Hurn P.D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 1998, 29:1666-1670.
37. Toung T.J., Chen T.Y., Littleton-Kearney M.T., Hurn P.D., Murphy S.J. Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J. Cereb. Blood Flow Metab. 2004, 24:1160-1166.
38. Tsuji K., Aoki T., Tejima E., Arai K., Lee S.R., Atochin D.N., Huang P.L., Wang X., Montaner J., Lo E.H. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005, 36:1954-1959.
39. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 2001, 345:1243-1249.
40. Wang X., Lee S.R., Arai K., Tsuji K., Rebeck G.W., Lo E.H. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 2003, 9:1313-1317.
41. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., Kotchen T., Curb J.D., Black H., Rossouw J.E., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003, 289:2673-2684.
42. Won C.K., Kim M.O., Koh P.O. Estrogen modulates Bcl-2 family proteins in ischemic brain injury. J. Vet. Med. Sci. 2006, 68:277-280.
43. Yagi K., Kitazato K.T., Uno M., Tada Y., Kinouchi T., Shimada K., Nagahiro S. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke 2009, 40:626-631.
44. Yang S.H., Shi J., Day A.L., Simpkins J.W. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000, 31:745-749. discussion 749-750.
45. Yang D.Y., Pan H.C., Chen C.J., Cheng F.C., Wang Y.C. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion. Neurol. Res. 2007, 29:274-282.
46. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest 2003, 112:1533-1540.
47. Zhang W., Sato K., Hayashi T., Omori N., Nagano I., Kato S., Horiuchi S., Abe K. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol. Res. 2004, 26:342-348.
48. Zhu H., Fan X., Yu Z., Liu J., Murata Y., Lu J., Zhao S., Hajjar K.A., Lo E.H., Wang X. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J. Cereb. Blood Flow Metab. 2010, 30(6):1137-1146.